Adjuvant Holdings CoTSE:4929 63 Altman Z2-Score is 10.43 as of Jul. 05, 2026, which is 12% above its 10-year median of 9.33. GuruFocus rates TSE:4929 with a GF Score™ of 63/100 and a GF Value™ of 円736.10 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,966 Consumer Packaged Goods companies, Adjuvant Holdings Co ranks better than 89.62% on this metric.
Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.
Good Sign:
Adjuvant Holdings Co has a Altman Z2-Score of 10.43, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.
The zones of discrimination were as such:
When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.
The historical rank and industry rank for Adjuvant Holdings Co's Altman Z2-Score or its related term are showing as below:
TSE:4929'
s Altman Z2-Score Range Over the Past 10 Years
Min: 7.89 Med: 9.33 Max: 10.43
Current: 10.43
During the past 13 years, Adjuvant Holdings Co's highest Altman Z2-Score was 10.43. The lowest was 7.89. And the median was 9.33.
Adjuvant Holdings Co (TSE:4929) Altman Z2-Score Explanation
The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
Altman Z2-Score does not apply to financial companies.
Adjuvant Holdings Co Altman Z2-Score Related Terms
Adjuvant Holdings Co Altman Z2-Score Historical Data
* Premium members only.
The historical data trend for Adjuvant Holdings Co's Altman Z2-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4929 vs PG, CL, KVUE: Altman Z2-Score Comparison
For the Household & Personal Products subindustry, Adjuvant Holdings Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adjuvant Holdings Co Altman Z2-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Adjuvant Holdings Co's Altman Z2-Score distribution charts can be found below:
* The bar in red indicates where Adjuvant Holdings Co's Altman Z2-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.
Adjuvant Holdings Co's Altman Z2-Score for today is calculated with this formula:
Z
=
6.56
*
X1
+
3.26
*
X2
+
6.72
*
X3
+
1.05
*
X4_2
=
6.56
*
0.5571
+
3.26
*
0.5268
+
6.72
*
0.0431
+
1.05
*
4.5371
=
10.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.
Adjuvant Holdings Co (TSE:4929) has a Altman Z2-Score of 10.43 as of Jul. 05, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Adjuvant Holdings Co and its competitors. This is 12% above median its historical median of 9.33. Over the past decade, Adjuvant Holdings Co's Altman Z2-Score has ranged from 7.89 to 10.43. According to the industry distribution chart, Adjuvant Holdings Co ranks #204 out of 1966 companies in the Consumer Packaged Goods industry, placing it in the top 10.4%.
Is Adjuvant Holdings Co's Altman Z2-Score too high?
Adjuvant Holdings Co's current Altman Z2-Score of 10.43 is 12% above median its 10-year median of 9.33. Over the past 10 years, this metric has ranged from a low of 7.89 to a high of 10.43. The Consumer Packaged Goods industry median Altman Z2-Score is 3.73. Adjuvant Holdings Co's value of 10.43 is 179.6% above this industry median. Based on the distribution chart, Adjuvant Holdings Co ranks #204 out of 1966 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Adjuvant Holdings Co has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adjuvant Holdings Co's Altman Z2-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Adjuvant Holdings Co ranks #204 out of 1966 companies for Altman Z2-Score. This places Adjuvant Holdings Co in the top 10% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 3.73. Adjuvant Holdings Co's value of 10.43 is 179.6% above this benchmark. Historically, Adjuvant Holdings Co's own Altman Z2-Score has ranged from 7.89 to 10.43 over the past decade. While the company's 10-year median is 9.33 vs. the industry median of 3.73, Adjuvant Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Consumer Packaged Goods company?
The median Altman Z2-Score among Consumer Packaged Goods companies is 3.73, based on 1,966 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adjuvant Holdings Co's current Altman Z2-Score of 10.43 is 179.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Adjuvant Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median Altman Z2-Score is 3.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adjuvant Holdings Co's current Altman Z2-Score is 10.43, which is 12% above median its own 10-year median of 9.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adjuvant Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Adjuvant Holdings Co (TSE:4929) is currently considered Fairly Valued. The stock's GF Value™ is 円736.10, compared to a current price of 円730.00 — trading 0.8% below its estimated fair value. The current Altman Z2-Score is 10.43, which is 12% above median its 10-year median of 9.33 and 179.6% above the Consumer Packaged Goods industry median of 3.73. Adjuvant Holdings Co's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Adjuvant Holdings Co (TSE:4929), the current Altman Z2-Score is 10.43 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adjuvant Holdings Co (TSE:4929) Overvalued in 2026?
Based on GuruFocus' analysis, Adjuvant Holdings Co stock appears to be undervalued.
The current stock price of 円730.00 is trading 0.8% below its estimated GF Value™ of 円736.10.
GuruFocus considers Adjuvant Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4929:
Altman Z2-Score: 10.43 (12% above median its 10-year median of 9.33)
GF Value™: 円736.10 vs. price of 円730.00 (0.8% below fair value)
Industry Position: 179.6% above the Consumer Packaged Goods median (#204 of 1966)
No single metric tells the full story. See the TSE:4929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.
63GF Score
Get the complete analysis for TSE:4929
Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4929 has been successfully added to your 
